La auténtica dimensión del colesterol-no-HDL: colesterol aterogénico

In fact, non-HDL-cholesterol should be an excellent marker of atherogenic cholesterol, and an major therapeutic target in patients with atherogenic dyslipidaemia. According with different clinical trials and with the epidemiological and mendelian studies, in patients with high cardiovascular risk, optimal level of cLDL will be under 70 mg/dl, and under 100 ng/dl for non-HDL-cholesterol; and in high risk patients, 100 mg/dl and 130 mg/dl, respectively.